StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Rajesh Satpute

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))23 Sept 2026via CNBC Awaaz.

Entry₹1,173Inferred
Target₹1,200
Total upside +2.30% (call closed)
Stop loss₹1,158-1.28% risk
Exit₹1,15823 Sept 2026, 1:10 pm
Stop-loss hit-1.28%
Follow Rajesh Satpute for new calls(34% target hit, 223 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Sept 2026
4 supporting0 opposing
Supports the BUY call (4)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·22 Sept · yesterday

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 5d ago

(opens in new tab)

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth

NewsNdtv-Profit·9 Sept · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Rajesh Satpute

Every call and its outcome